【治疗性疫苗HperV有望2013年底面向患者】第一阶段治愈率100%，... [复制链接]

7. AGENUS (HerpV, HSV-2)(2017): HerpV also known as AG-707 is an interesting vaccine intended for HSV2 where that it attacks the virus by producing more CD4 and CD8 Killer T cells. What I like about this vaccine is that it is definitely unique in how it operates, it could potentially cure HSV. It also had (although small) a very successful Phase I study. Its major obstacle is funding it seems, I almost have to think they will have to get a larger pharmaceutical company to back them up. Their financials are not very good. But things could turn around quickly if they get someone to back them up or possibly grant funding for their research. The latest news I have on them is July 27,2010 : http://www.agenusbio.com/docs/herpv/0727.pdf , June 27,2011: http://www.agenusbio.com/docs/pr/2011/0627.pdf , UPDATE: Rumored they are trying to get backing for Phase II study July 14, 2011: http://www.herpessymptoms-inmen.com/http:/www.herpessymptoms-inmen.com/is-a-vaccine-for-genital-herpes-just-around-the-corner/ , Update Planned Phase II suspected for HerpV mid 2012 September 26, 2011: http://www.proactiveinvestors.com/companies/news/18832/agenus-reports-positive-results-for-its-herpv-drug-18832.html

是这个吗？怎么说要2017年得？

请问LZ哪里看到说2013年或2014年有的上市？我找了好久都没

回复 84楼alex_lou的帖子

VICL的疫苗貌似没说1/2阶段的临床试验很成功，我看到时说准备开始的？

回复 87楼alex_lou的帖子

没事，感谢你啊，帮我们收集信息。辛苦了！！